Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2026-01-22 @ 7:41 AM
Study NCT ID:
NCT00232206
Status:
TERMINATED
Last Update Posted:
2011-05-18
First Post:
2005-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer
Sponsor:
Providence Health & Services
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PPMC-EACRI-IRB-05-032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None